Considerable evidence now exists to support the notion that the 50-kDa sheep erythrocyte binding protein, T1l, represents an essential cell surface component of a human T-cell-lineage activation pathway. Furthermore, it is known that the human T-cell antigen-major histocompatibility complex (MHC) receptor complex T3-Ti is capable of regulating cell growth mediated by the T1l structure. Here we show that, within the T3' thymocyte compartment, T3-Ti crosslinking rapidly inhibits Tl1-initiated interleukin 2 (IL-2) gene transcription and translation. This inhibition is restricted to the IL-2 gene (IL2) as transcription of both the IL-2 receptor gene (IL2R) and the Ti fl-chain gene (TCRB) are not affected (human gene designations are in parentheses). Perhaps more importantly, T3-Ti-mediated IL-2 inhibition of this type is not operational in peripheral T lymphocytes. The results imply that the majority of T3' thymocytes are functionally distinct from peripheral T lymphocytes despite their T3' phenotype and may possess a unique endogenous regulatory component for suppressing IL-2 gene activity. Moreover, since IL-2 is likely rate-limiting for growth within the thymus, the findings provide one plausible mechanism for thymic selection-namely, T3-Ti crosslinking of thymocytes upon interaction with selfmajor histocompatibility complex inhibits clonal expansion of high-affinity autoreactive cells.Discrete stages of human intrathymic ontogeny have been identified on the basis of unique T-cell-lineage surface glycoproteins as defined by monoclonal antibodies (1-5). The earliest T-lineage cells express the sheep erythrocyte binding protein, T11, but no other T-lineage cell-specific markers (T11+ T6-T4-T8-T3-) (stage I). In this population, the T-cell antigen receptor Ti a-and ,3-chain genes (TCRA* and TCRB*) remain largely in germ-line configuration (6). With further maturation, the thymic leukemia-like molecule T6 is acquired, and T-lineage cell-specific T4 and T8 molecules are coexpressed to various degrees in the same cell (T11+ T6+ T4+ T8+ T3) (stage II). Ti gene rearrangements and maximal Ti p-chain gene transcriptional activity are present in stage II thymocytes (7). Both stage I and stage II thymocytes are located in the cortex and represent -10% and =60% of the total thymocyte population, respectively. With even further maturation, Ti a-chain gene transcription becomes maximal (7), the expression of the cortical-specific marker T6 ceases, and the three T3 surface glycoproteins and Ti a and ,8 chains are coordinately expressed, predominantly in the medullary compartment (8). Furthermore, thymocytes are driven to terminally differentiate in one of two directions: either the T4 molecule is maintained and the T8 molecule is lost, or reciprocally, T8 is maintained and T4 is lost (T11+ T6-T4+ T8-T3+ or T11+ T6-T4-T8+ T3+) (stage III). Although stage III thymocytes represent only a fraction of the total thymocyte population (-30% of thymocytes), antigen responsiveness and, hence, functional competence are restricted t...